These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 27449042)
1. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
2. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related]
3. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
4. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Jia Q; Zhang X; Deng T; Gao J Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193 [TBL] [Abstract][Full Text] [Related]
5. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics. Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969 [TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986 [TBL] [Abstract][Full Text] [Related]
7. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; CalabrĂ² E; Pastorino U; Sozzi G Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294 [TBL] [Abstract][Full Text] [Related]
8. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer. Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447 [TBL] [Abstract][Full Text] [Related]
10. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317 [TBL] [Abstract][Full Text] [Related]
11. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996 [TBL] [Abstract][Full Text] [Related]
12. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. O'Brien CA; Kreso A; Ryan P; Hermans KG; Gibson L; Wang Y; Tsatsanis A; Gallinger S; Dick JE Cancer Cell; 2012 Jun; 21(6):777-92. PubMed ID: 22698403 [TBL] [Abstract][Full Text] [Related]
13. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377 [TBL] [Abstract][Full Text] [Related]
14. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways. Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Ma L; Lai D; Liu T; Cheng W; Guo L Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681 [TBL] [Abstract][Full Text] [Related]
16. ABCG2: the key to chemoresistance in cancer stem cells? An Y; Ongkeko WM Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828 [TBL] [Abstract][Full Text] [Related]
17. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Pang R; Law WL; Chu AC; Poon JT; Lam CS; Chow AK; Ng L; Cheung LW; Lan XR; Lan HY; Tan VP; Yau TC; Poon RT; Wong BC Cell Stem Cell; 2010 Jun; 6(6):603-15. PubMed ID: 20569697 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts. Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358 [TBL] [Abstract][Full Text] [Related]
20. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]